1-5 of 5 results for In Re: Pfizer, Inc. Securities Litigation
Sort by:
  • November 28, 2005

    Merck culls 7,000 jobs in bid to save $4bn

    ...drugmakers have already begun moving in the same direction as the industry tries...boost growth and improve efficiency. In April, Pfizer, the world’s biggest drugmaker...it would cut costs by $4bn by 2008, in response to falling sales and patent expiries...around the halls of Merck saying we’re number eight.” One problem Mr Clark will face for years is the ongoing litigation over Vioxx, a painkiller Merck withdrew...Timothy Anderson, analyst at Prudential Securities, said: “Merck is likely to remain... By Christopher Bowe in New York
  • November 28, 2005

    Merck to cut 7,000 jobs and close plants

    ...drugmakers have already begun moving in the same direction as the industry tries...boost growth and improve efficiency. In April, Pfizer, the world’s biggest drugmaker...it would cut costs by $4bn by 2008, in response to falling sales and patent expiries...around the halls of Merck saying we’re number eight.” One problem Mr Clark will face for years is the ongoing litigation over Vioxx, a painkiller Merck withdrew...Timothy Anderson, analyst at Prudential Securities, said: “Merck is likely to remain... By Christopher Bowe in New York
  • November 29, 2005

    Merck plans 7,000 job cuts

    ...drugmakers have already begun moving in the same direction as the industry tries...boost growth and improve efficiency. In April, Pfizer, the world's biggest drugmaker...it would cut costs by $4bn by 2008, in response to falling sales and patent...around the halls of Merck saying we're number eight." One problem Mr Clark will face for years is the litigation over Vioxx, a painkiller Merck withdrew...Timothy Anderson, analyst at Prudential Securities, said: "Merck is likely to remain... By Christopher Bowe in New York
  • January 4, 2005

    Vioxx saga continues to weigh on Merck

    ...higher estimate had been originally cited in congressional hearings, Mr Gilmartin...make these characterisations, we're very proud. [Our actions were] totally...investigations by Congress, the US Securities and Exchange Commission and the US Department of Justice. There is also mooted litigation in Canada, Brazil, Israel, France and...affect Celebrex and Bextra, both made by Pfizer, which has stressed that a variety...or the absence of treatment. "We're getting into a witch hunt," says one... By Andrew Jack in London
  • January 5, 2005

    Vioxx saga continues to weigh on Merck

    ...higher estimate had been originally cited in congressional hearings, Mr Gilmartin...make these characterisations, we're very proud. [Our actions were] totally...investigations by Congress, the US Securities and Exchange Commission and the US Department...There are also mooted litigations in Canada, Brazil, Israel, France and...affect Celebrex and Bextra, both made by Pfizer, which has stressed that a variety...or the absence of treatment. "We're getting into a witch-hunt," says...in the courts, with the first Vioxx litigation anticipated in Alabama or Texas during... By Andrew Jack
1-5 of 5 results
Date range filter

Keyword filter